Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia

World Journal of Urology

Volumn 28, Issue 6, 2010, Pages 677-680

  Morote, Juan ^a   Rigau, Marina ^a   Garcia, Marta ^a   Mir, Carmen ^a   Ballesteros, Carlos ^a   Planas, Jacques ^a   Raventós, Carles X ^a   Placer, José ^a   de Torres, Inés M ^a   Reventós, Jaume ^a   Doll, Andreas ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

High grade prostate intraepithelial neoplasia; PCA3; Prostate cancer

Indexed keywords

PROSTATE CANCER ANTIGEN 3, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOPSY; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BIOPSY; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 78049474696     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0580-0     Document Type: Article

References (14)

1. Morote J, Fernández S, Alaña L et al (2008) PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res 14: 2617-2622.
2. Freedland SJ, Partin AW (2006) Prostate-specific antigen: update 2006. Urology 67: 458-460.
3. Bussemakers MJ, van Bokhoven A, Verhaegh GW et al (1999) DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59: 5975-5979.
4. de Kok JB, Verhaegh GW, Roelofs RW et al (2002) DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62: 2695-2698.
5. Hessels D, Klein Gunnewiek JM, van Oort I et al (2003) DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 44: 8-15.
6. Fradet Y, Saad F, Aprikian A et al (2004) UPM3, a new molecular urine test for the detection of prostate cancer. Urology 64: 311-315.
7. Tinzl M, Marberger M, Horvath S, Chypre C (2004) DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer. Eur Urol 46: 182-186.
8. Groskopf J, Aubin SM, Deras IL et al (2006) APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 52: 1089-1095.
9. Marks LS, Fradet Y, Deras IL et al (2007) PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 69: 532-535.
10. Chun FK, de la Taille A, van Poppel H et al (2009) Prostate Cancer Gene 3 (PCA3): development and internal validation of a novel biopsy nomogram. Eur Urol 59: 659-668.
11. Deras IL, Aubin SM, Blase A et al (2008) PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 179: 1587-1592.
12. Haese A, de la Taille A, van Poppel H et al (2008) Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol 54: 1081-1088.
13. van Gils MP, Hessels D, van Hooij O et al (2007) The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance. Clin Cancer Res 13: 939-943.
14. Popa I, Fradet Y, Beaudry G, Hovington H, Tetu B (2007) Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization. Mod Pathol 20: 1121-1127.